You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Have you sometimes, like myself, wondered what happened to Lazarus after resurrection? How did he live his life? Did he change or alter his ways after he was resurrected? Did he have more purpose and intentionality in his life after Jesus called him out of the tomb? What must happen to us in our mind, heart and soul if we are given a second chance in life? Journey with me as I view the story of Lazarus through the unique lens of my life experience as a Jesus follower, a cancer researcher, a medical doctor, and a cancer patient. Lazarus & Me talks about my personal transition from a fundamentally flawed understanding of science being the hero to God as the hero. Discover how miracles represen...
When you reflect on your life, does it seem like a series of random events or can you see a pattern emerge that points to the artistry of a Master Designer? When a leading cancer researcher and world-renowned oncologist is given a terminal cancer diagnosis, the doctor who is now a patient has an experiential conversation with the Lord. While reflecting on some of the major events of his life, Asher gains a perspective that gives him peace for what lies ahead. When he can see the intentional, exquisite craftsmanship of his past, he knows he can trust his future to the same Master Craftsman. Grab a tissue or two as you get a glimpse of a father who may soon leave this earth and the son he loves. Enjoy the customized illustrations that depict the occasion of each tapestry thread. Let Asher's story bolster your faith that God is in control of all things, and that He weaves His love and grace into the fabric of our very being.
INSPIRING! LIVING VICTORIOUSLY THROUGH LIFE'S DARKEST MOMENTS Have you ever wondered what happened to Lazarus after Jesus resurrected him from death? Lazarus was given an extension of life and the time spent on earth. Do you think Lazarus lived a drastically different life after resurrection? Would you think and live differently if you were given such an opportunity? Dr. Asher Chanan-Khan, a world-renowned cancer researcher and clinical oncologist, experienced such a "Lazarus moment" in his life when his own terminal cancer was miraculously paused, rendering him an extension of life. Now, 15 years later, Dr. Asher ponders upon his living in these Lazarus moments. Read on to learn about Godâ€...
Why is there such endless strife between the Muslim and the Christian world , despite the Quaran endorsing Jesus Christ, His immaculate conception by the Holy Spirit and expecting Muslims to believe His message? Today the Muslim world fails to recognize what exactly is the message of Jesus Christ and His role in securing eternity for mankind. Both Muslims and Christians are largely ignorant what the other believes and why there is still relentless tension on the earth. This book focuses on the fundamental irreconcilable differences between the Christian and Islamic faiths, that are rooted in the texts of the Quran and Bible, and is written from experience in both faiths.
Immunomodulatory (IMiDs) drugs are a new class of anticancer agents that has made a tremendous impact on the treatment of patients with various malignant diseases, including blood cancers and several cancers of the solid organs. Their popularity in prescribing is based on several important characteristics including: (1) oral bioavailability, (2) non-chemotherapeutic, (3) extremely well-tolerated in all age groups, (4) ability to activate patient's own immune response against cancer, (5) ease of combination with other agents such as chemotherapy resulting in higher responses as well as (6) variability of anticancer activity and a number of cancers. While there is a lot of literature published on these agents, there is no textbook that provides a comprehensive resource for clinicians and researchers regarding these agents and their rapidly emerging role in cancer medicine.
Therapeutic options for patients with myeloma have dramatically changed over the past 10 years. Beginning with the advances in therapy resulting from the use of high-dose therapy and autologous bone marrow or stem cell tra- plant, we have more than doubled the median survival for patients as a whole, and have now have a wealth of different biology -based treatment approaches for our patients in all disease stages. This book represents state-of-the-art information from many of the leaders in the plasma cell disorders world. Sections focusing on disease pathogenesis and biology, chemotherapy-based approaches, immune -based therapies, currently approved novel agents, developing targets, support...
The MediFocus Guidebook on Chronic Lymphocytic Leukemia is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Chronic Lymphocytic Leukemia, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Chronic Lymphocytic Leukemia, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks. This Guidebook was updated on February 2, 2012.
Myeloma is the second-most common hematologic cancer, accounting for approximately 1 percent of all cancers and 2 percent of all deaths from cancer. In recent years there have been major and significant advances in the diagnosis, imaging, molecular pathogenesis, and therapy of myeloma. This book describes these advances in a single, practical volume, placing them in the context of daily clinical practice. Different myeloma subtypes are discussed in individual chapters, integrating etiology, pathogenesis, molecular pathology, histology, and therapy in a single place for each condition. The book begins by discussing epidemiology, imaging techniques, pathogenesis, and other general considerations. Conditions covered in detail include multiple myeloma, POEMS syndrome, Castleman's syndrome, Waldenstrom's macroglobulinemia, amyloidosis and MGUS. Featuring color illustrations, and written and edited by leading authorities in the field, Myeloma provides readers with the information they need to diagnose and manage these complex disorders.
This is a comprehensive, state-of-the-art guide to the diagnosis, treatment, and biology of multiple myeloma and related plasma disorders. Edited and written by a multidisciplinary group of recognized authorities from the Mayo Clinic, it presents clear guidelines on diagnosis and therapy and covers all aspects of multiple myeloma, from molecular classification and diagnosis, to risk stratification and therapy. Closely related plasma cell disorders such as solitary plasmacytoma, Waldenstrom macroglobulinemia, and light chain amyloidosis are discussed in detail as well. The book addresses often overlooked topics, including the role of radiation therapy, vertebral augmentation, and supportive care. Our understanding of this group of disorders is developing at an unprecedented rate, and Multiple Myeloma meets the need among oncologists and hematologists for a clear, timely, and authoritative resource on their biology, diagnosis, and treatment.